Amy Baxter
Staff ReporterAmy Baxter is a staff reporter for PharmaVoice. Before joining the team, she served as an editor and reporter in the B2B healthcare space for eight years at Health Exec and Home Health Care News. She also covered the retail industry as editor of Retail Leader, and hosted an Hermes award-winning weekly podcast and video interview series, Trend Talk, featuring industry executives and experts. A lifelong sailor, Amy has taken her media skills on the water to cover regattas and sailing events across the country. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Race to Mackinac Island. She is based in Florida.
31 articles by Amy Baxter
-
Behind the powerful computations, AI’s role in pharma is still beset by challenges
June 12, 2024 -
FDA’s platform designation aims to ease R&D pain points
June 11, 2024 -
Regenerative cell therapy biotech uses IPO to blast into human trials
June 5, 2024 -
In an era of big patent losses, drug launches need years of runway
June 3, 2024 -
Deadline looms for Chinese biotech contracts
May 31, 2024 -
As weight loss booms, drugmakers look for an edge with oral options
May 28, 2024 -
Pfizer and Lilly are elbowing into the direct-to-consumer market. Will it work?
May 22, 2024 -
Execs from Bayer, Kite and Orca sound off on their launch strategies for cell and gene therapies
May 20, 2024 -
As Lilly surges, headwinds against its weight loss drugs are growing
May 15, 2024 -
Biosimilars are gaining ground. The IRA could push them even further next year.
May 13, 2024 -
FDA’s new diagnostic rules draw pharma criticism
May 6, 2024 -
As AI proliferates in pharma, regulators look to catch up in clinical trials
May 1, 2024 -
How a biotech exec is leveraging Big Pharma lessons to advance tRNA
April 29, 2024 -
AbbVie and Regenxbio’s ‘multibillion-dollar opportunity’ in vision loss gene therapy
April 24, 2024 -
WuXi partnerships at risk as lawmakers target Chinese ties to biopharma
April 22, 2024 -
3 patent expirations in 2024 and how companies are pivoting
April 17, 2024 -
Where the GLP-1 weight loss market goes will depend on data
April 15, 2024 -
What’s old is new: The revival of a one-time radiotherapy cancer treatment
April 10, 2024 -
Cutting pills. Rationing insulin. How Americans struggle to pay for drugs.
April 9, 2024 -
As antimicrobial resistance looms large, a nonprofit teams up with Big Pharma to intervene
April 3, 2024 -
To penetrate crowded GLP-1 field, Rivus Pharma is taking a metabolic approach
March 29, 2024 -
Takeda plots ‘unprecedented patient diversity’ for psoriasis drug that could compete with BMS
March 27, 2024 -
With historic MASH approval, Madrigal preps for launch and a public offering
March 20, 2024 -
5 Big Pharma CEOs who saw major pay bumps in 2023
March 18, 2024 -
These biotech hotspots are ripe for IPOs
March 13, 2024